Vaccinex, Inc. (VCNX) Gross margin 2018–2021
Vaccinex, Inc. (VCNX) gross margin by fiscal year — reported gross profit divided by reported revenue.
99.8%FY2021 · since FY2018: 77.9% → 99.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | 99.8% | +31.6 pp |
| FY2020 | 68.2% | +165.7 pp |
| FY2019 | -97.5% | -175.4 pp |
| FY2018 | 77.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VCNX financial trends
VCNX RevenueVCNX Net incomeVCNX Net marginVCNX Gross profitVCNX Operating incomeVCNX Operating marginVCNX Operating cash flowVCNX Free cash flowVCNX Capital expendituresVCNX Return on equityVCNX Stock buybacksVCNX Dividends paidVCNX Total assetsVCNX Total liabilitiesVCNX Shareholders’ equityVCNX overview →